Login

Switch On Your HIV Smarts.

Dolutegravir Looks Good in Another Advanced Clinical Trial

Dolutegravir Looks Good in Another Advanced Clinical Trial

, by Reilly O'Neal

Learn more about this next-generation integrase inhibitor and see how it stacks up against popular HIV drug regimen Atripla. Read More

Reducing Inflammation: Do Some HIV Drugs Work Better Than Others?

Reducing Inflammation: Do Some HIV Drugs Work Better Than Others?

, by San Francisco AIDS Foundation

New research suggests starting antiretroviral treatment reduces inflammation caused by HIV infection—but plenty of questions remain. Read More

Ask a Guinea Pig: What Do I Need to Know Before Joining a PrEP Trial?

Ask a Guinea Pig: What Do I Need to Know Before Joining a PrEP Trial?

, by Matt Sharp

BETA's new column shares an insider perspective on taking part in clinical trials. Thinking of joining a study of PrEP—a pill a day for HIV prevention? Start here. Read More

New HIV Drugs on the Way?

New HIV Drugs on the Way?

, by San Francisco AIDS Foundation

New HIV treatment options may be available by late summer. HIVandHepatitis.com's Liz HIghleyman gives the scoop on elvitegravir, cobicistat, and the "Quad" pill. Read More

Ask a Pharmacist: The Skinny on Diet Pills for People with HIV

Ask a Pharmacist: The Skinny on Diet Pills for People with HIV

, by Jennifer Cocohoba, PharmD, AAHIVE

Introducing BETA's newest column: "Ask a Pharmacist." Jennifer Cocohoba, PharmD, addresses a question that's cropping up in her HIV clinic now that summer is here: "What can I take to lose weight?" Read More